He discusses new and emerging agents that may cause drug-induced lung disease, how classic toxicities of medications are presenting differently, and more.
In part 1 of this podcast series, Vincent Lo Re, MD, talks about the current knowledge gaps around hepatitis C virus screening, as well as how health care providers can implement better screening protocols...
In this podcast, Dr Levine discusses the diagnosis of PCOS in the primary care setting, addressing associated cardiovascular risks, and the 5 main goals of treatment.
James Matera, DO, details advances in the treatment of hepatitis C virus in patients with end-stage renal disease. He also explains why it may be beneficial to defer hepatitis C treatment until after renal...
Bardia Nourbakhsh, MD, from Johns Hopkins University School of Medicine discusses the different diagnosis tools for multiple sclerosis, as well as challenges in diagnosis.
